Company
CEO Message
NanoCarrier was established to develop drugs which utilize the nanotechnology researched by Dr. Kataoka Kazunori, Professor Emeritus at the University of Tokyo, Teruo Okano, Emeritus Professor at Tokyo Women's Medical University, and their colleagues. The company uses polymeric micelles (micellar nanoparticles technology), which is technology originating in Japan, as drug carriers, and creates new value in cancer therapy through the integration of medicine and engineering.
NanoCarrier is currently focusing on the development of drug delivery systems (DDS) for drugs such as anti-cancer therapeutics and nucleic acids which need to be delivered reliably in large doses directly to the site of disease. The platform technology for maximizing a drug's efficacy whilst minimizing side effects can be applied not only to next-generation therapeutics but also to a wide range of other applications. NanoCarrier aims to reduce the burden on patients undergoing treatment, enabling them to be treated whilst leading a normal life, without being hospitalized.
The company already has a number of products in the pipeline which are in the late development stage and is proud of being one of only a handful of Japanese bioventures which have come this far. NanoCarrier is committed to creating new value and helping people lead healthier, happier lives.
Tetsuhito Matsuyama,
President & CEO
Corporate Profile
| Corporate Name | NanoCarrier Co.,Ltd. |
|---|---|
| Location |
Head office and Lab
Chuou 144-15, 226-39 Wakashiba, Kashiwa, Chiba, 277-0871, Japan Tokyo Office
Ohnoya-Kyobashi Bldg 1-4-10 Kyobashi,Chuo-ku, Tokyo, 104-0031, Japan iCONM laboratory
3F Innovation Center of NanoMedicine(iCONM) 3-25-14 Tonomachi, |
| Establishment | June 14, 1996 |
| President and CEO | Tetsuhito Matsuyama |
| Capital | 4,135 million yen (As of March 31, 2020) |
| Number of employees & management | 37 (As of March 31, 2020) |
| Scopes of Business | R&D and production of pharmaceuticals using micellar nanoparticles technology. |
Management
Tetsuhito Matsuyama
President and CEO
| Apr. 1986 | Joined Mitsubishi Corporation |
|---|---|
| May 2003 | Director, COO and CFO, and President & CEO of Medical ProteoScope Co., Ltd. |
| Oct. 2007 | Executive Officer of CSK Institute for Sustainability, Ltd. |
| May 2010 | Among others, General Manager of Business Development Division, Executive Officer and COO of Overseas Business Group of Lawson Inc. |
| Nov. 2012 | Among others, consultant, Director, and Senior Managing Director of Nitto Boseki Co., Ltd. |
| Dec. 2014 | Advisor to the Company |
| Jan. 2015 | CFO and Head of CEO Office of the Company |
| Jun. 2015 | Director, CFO and Head of CEO Office of the Company |
| Jun. 2018 | Director of Entrust Inc. (current) |
| Jul. 2018 | Director, CSFO and Head of CEO Office of the Company |
| Nov. 2019 | President and CEO of the Company(current) |
Shiro Akinaga, Ph.D.
Board of Director
| Apr. 1981 | Joined Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 1994 | Senior Researcher at pharmaceutical research center of Kyowa Hakko |
| Apr. 2001 | Therapeutic Area Manager of oncology group at Drug Discovery Research Division of Kyowa Hakko |
| Apr. 2004 | Deputy Director, Clinical Development I Department, R&D Division of Kyowa Hakko |
| Apr. 2006 | Director of International Development Department and Director of Clinical Development I Department, R&D Division of Kyowa Hakko |
| Oct. 2008 | Director, Clinical Development I Department, Development Division of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.) |
| Mar. 2011 | Executive Officer (International Development) of Kyowa Hakko Kirin |
| Mar. 2013 | Fellow of Kyowa Hakko Kirin |
| Mar. 2017 | Director and CSO of AccuRna, Inc. |
| Nov. 2018 | Chairman of the board, CEO of AccuRna, Inc. |
| Jun. 2020 | Director of NanoCarrier Co., Ltd. |
| Sep. 2020 | Director, Head of R&D Division and CSO (current) |
Koji Fujimoto
Managing Director of Corporate Division
| Apr. 1996 | Joined Nissan Construction Co., Ltd. (currently Rinkai Nissan Construction Co., Ltd.) |
|---|---|
| Nov. 2002 | Joined the Company |
| Jul. 2005 | Manager of General Affairs and HR Section, Administration Department of the Company |
| May 2015 | Deputy Director of Administration Department of the Company |
| Apr. 2017 | Director of General Affairs and HR Department of the Company |
| Dec. 2019 | Managing Director of Corporate Division and Director of General Affairs and HR Department of the Company (current) |
| Jun. 2020 | Director, Head of Corporate Division (current) |
Teruo Okano, Ph.D.
Board of Director
| Apr. 1979 | Assistant Professor, Institute of Biomedical Engineering, Tokyo Women’s Medical University |
|---|---|
| Nov. 1987 | Associate Professor, Institute of Biomedical Engineering, Tokyo Women’s Medical University |
| Jan. 1994 | Professor at Institute of Biomedical Engineering, Tokyo Women’s Medical University Affiliate Professor at Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah (U.S.) (current) |
| Jun. 1996 | Director of the Company (current) |
| Apr. 1999 | Professor and Director, Institute of Biomedical Engineering, Tokyo Womens Medical University |
| Apr. 2001 | Director and Professor at Institute of Advanced Biomedical Engineering and Science, Tokyo Women’s Medical University |
| May 2001 | Director of CellSeed Inc. |
| Apr. 2014 | Professor Emeritus and Professor by Special Appointment at Tokyo Women’s Medical University (current) |
| Sep. 2016 | Director of Cell Sheet Tissue Engineering Center, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah (U.S.) (current) |
| Apr. 2020 | Director of Institute of Advanced BioMedical Engineering and Science, Tokyo Women’s Medical University (current) |
Kazunori Kataoka, Ph.D.
Board of Director
| Apr. 1979 | Assistant, lecturer and Assistant Professor at Institute of Biomedical Engineering, Tokyo Women’s Medical University |
|---|---|
| Apr. 1989 | Assistant Professor and Professor at Faculty of Industrial Science and Technology, Tokyo University of Science |
| Apr. 1998 | Professor at School of Engineering, the University of Tokyo |
| Jul. 2004 | Professor at Graduate School of Medicine, the University of Tokyo (concurrent) |
| Jul. 2015 | Director General of Innovation Center of NanoMedicine (current) |
| Apr. 2016 | Professor by Special Appointment at the University of Tokyo (current) |
| Jun. 2016 | Professor Emeritus of the University of Tokyo (current) |
| Jul. 2016 | Vice-Director General at Kawasaki Institute of Industry Promotion (current) |
| Jun. 2020 | Director of NanoCarrier Co., Ltd. (current) |
Manish Mishra, M.D., Ph.D.
Board of Director
| Jun. 1991 | Founder & CEO of P.C. Point Computers Corporation (India) |
|---|---|
| Apr. 1996 | President & CEO of ENIX Corporation (India) |
| Jan. 2001 | Fund Manager of APAX GLOBIS PARTNERS (currently GLOBIS CAPITAL PARTNERS & Co.) |
| Mar. 2004 | Director, COO and CFO of the Company |
| Apr. 2008 | Executive Director of Microsoft Japan Co., Ltd. |
| Mar. 2012 | President & CEO of Bridge & Sun Corporation (current) |
| Jun. 2019 | Director of the Company (current) |
Kanshiro Noguchi
Corporate Auditor
| Apr. 1970 | Nippon Chemiphar Co.,Ltd. |
|---|---|
| Apr. 1997 | Sales Management Manager, Nippon Chemiphar Co.,Ltd. |
| Dec. 1999 | Director, Safety Research Institute for Chemical Compounds Co., Ltd. |
| May. 2002 | Managing Director, Safety Research Institute for Chemical Compounds Co., Ltd. |
| Feb. 2008 | Corporate Auditor, JFC Sports Vanguard, INC. |
| Feb. 2009 | Business Management Deputy Manager, Tokyo Board Industries Co.,Ltd. |
| Apr. 2009 | Administration Manager, Tokyo Board Industries Co.,Ltd. |
| Jun. 2009 | Corporate Auditor, NanoCarrier Co.,Ltd. (Current) |
Tadashi Morishima
Auditors
| Apr. 1972 | Arthur Andersen Accounting Firm |
|---|---|
| Sep. 1988 | Representative partner, Arthur Andersen Worldwide (present Azusa Audit Office) |
| Nov. 1993 | Representative, Morishima CPA Office (Current) |
| Oct. 1999 | Auditor, NanoCarrier Co., Ltd. (Current) |
Mieko Nakayama
Auditors
| Apr. 1985 | Joined American Family Life Assurance Company of Columbus |
|---|---|
| Apr. 2002 | Joined the Legal Training and Research Institute of Japan |
| Oct. 2003 | Registered with the Bar (admitted to the Daiichi Tokyo Bar Association) Joined Makoto Law & Accounting Firm |
| Apr. 2010 | Partner of Haruka Sogo Law Firm (current) |
| Jun. 2017 | Auditor, NanoCarrier Co., Ltd. (Current) |
